Overview
ABBV market data
Price History
ABBV price chart
Valuation & Profitability
- P/E (TTM)
- 68.90 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.38 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.21 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 2.8% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 9.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $190.75 – $267.47 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $434.8B · P/B 94.44 · P/S 6.75.
Company News
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?The Motley Fool · Aug 13, 2026, 8:45 PM
Wolfe Research Upgrades AbbVie to Outperform, Announces $300 Price TargetBenzinga · Aug 13, 2026, 5:14 PM
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · Aug 11, 2026, 9:01 PM
BNP Paribas Maintains Neutral on AbbVie, Raises Price Target to $247Benzinga · Aug 11, 2026, 5:55 PM
Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $260Benzinga · Aug 10, 2026, 4:02 PM
Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) EstimateBenzinga · Aug 10, 2026, 11:22 AM
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026Globenewswire Inc · Aug 7, 2026, 11:00 AM
Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'Benzinga · Aug 6, 2026, 7:41 AM
8-K filing — AbbVie Inc. (ABBV)SEC EDGAR · Aug 5, 2026, 9:17 PM
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?The Motley Fool · Aug 5, 2026, 8:15 PM